selenious acid has been researched along with Neuronal Ceroid-Lipofuscinoses in 2 studies
Selenious Acid: A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.
Neuronal Ceroid-Lipofuscinoses: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Naidu, S | 1 |
Maumanee, I | 1 |
Olson, J | 1 |
Borel, J | 1 |
Moser, H | 1 |
Santavuori, P | 1 |
Westermarck, T | 1 |
Rapola, J | 1 |
Pohja, P | 1 |
Moren, R | 1 |
Lappi, M | 1 |
Vuonnala, U | 1 |
2 other studies available for selenious acid and Neuronal Ceroid-Lipofuscinoses
Article | Year |
---|---|
Selenium treatment in neuronal ceroid-lipofuscinosis.
Topics: Child; Child, Preschool; Drug Therapy, Combination; Erythrocytes; Follow-Up Studies; Glutathione Per | 1988 |
Antioxidant treatment in Spielmeyer-Sjögren's disease.
Topics: Adolescent; Adult; Antioxidants; Ascorbic Acid; Butylated Hydroxytoluene; Child; Drug Therapy, Combi | 1985 |